siRNA, Anti-AGBL4, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT51092WQ-2OMe)

The product SIRGT51092WQ-2OMe is a type of small interfering RNA (siRNA) that targets AGBL4 gene and regulates the expression of gene. The siRNA interferes with the expression of AGBL4 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001323573.1
Alternative Names CCP6
Related Diseases Cardiofaciocutaneous Syndrome 3
Purification HPLC
Target Gene
Gene ID 84871
Uniprot ID Q5VU57
Sub Cat Target Species Modification Scale  
SIRGT52092WQ-2F AGBL4 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT53092WQ-2MOE AGBL4 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT54092WQ-LNA AGBL4 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT51092WQ-RB AGBL4 Human Ribo-modified Inquiry
SIRGT52092WQ-BB AGBL4 Human Backbone-modified Inquiry

Related Products